Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.91
↑ 93% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-13.83
Historical baseline
PeriodValueYoY Change
2024-0.91+75.3%
2023-3.68-234.9%
2022-1.10+75.0%
2021-4.40+85.8%
2020-30.89+26.4%
2019-41.99-